Genomic screening for blood-borne viruses in transfusion settings

Vox Sanguinis

Volumn 74, Issue SUPPL. 2, 1998, Pages 119-123

  Lee, Helen H ^a,b   Allain, J P ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b MEDICAL RESEARCH COUNCIL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD DONOR; BLOOD TRANSFUSION; CONFERENCE PAPER; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HUMAN IMMUNODEFICIENCY VIRUS; LIGASE CHAIN REACTION; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SCREENING; VIRUS DETECTION; VIRUS GENOME;

EID: 0031822065     PISSN: 00429007     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1423-0410.1998.tb05408.x     Document Type: Conference Paper

References (22)

1. Lee H, Morse S, Olsvik Ø. Nucleic Acid Amplification Technologies: Application to Disease Diagnosis. Natick, MA: Eaton, 1997.
2. Schreiber GB, Busch MP, Kleinman SH, Korelitz JJ, The risk of transfusion-transmitted viral infections. N Engl J Med 1996; 334:1685-90.
3. Williamson LM, Heptonstall J, Soldan K. A SHOT in the arm for safer blood transfusion. Br Med J 1996; 313:1221-2.
4. Sugitani M, Inchauspé G, Shindo M, et al. Sensitivity of serological assays to identify blood donors with hepatitis C viraemia. Lancet 1992, 339:1018-9.
5. Vrielink H, van der Poel CL, Reesink HW, et al. Transmission of hepatitis C virus by anti-HCV-negative blood transfusion. Vox Sang 1995, 68:55-6.
6. Blajchman MA, Bull SB, Feinman SV. Post-transfusion hepatitis: impact of non-A,non-B hepatitis surrogate tests. Lancet 1995; 345: 21-5.
7. Liang TJ, Bodenheimer HC, Yankee R, et al. Presence of hepatitis B and C viral genomes in US blood donors as detected by polymerase chain reaction amplification. J Med Virol 1994; 42:151-7.
8. Iizuka H, Ohmura K, Ishijima A, et al, Correlation between anti-HBc titres and HBV DNA in blood units without detectable HBsAg. Vox Sang 1992; 63:107-11.
9. Mosley JW, Stevens CE, Aach RD, et al. Donor screening for antibody to hepatitis B core antigen and hepatitis B virus infection in transfusion recipients. Transfusion 1995; 35:5-12.
10. Lai ME, Farci P, Figus A, et al. Hepatitis B virus DNA in the serum of Sardinian blood donors negative for hepatitis B surface antigen. Blood 1989; 73:1709.
11. CPMP. The application of genome amplification technologies (GAT) to plasma fractionation pools. CPMP/BWP/390/97 (rev. 6).
12. Nubling CM, Wilkommen H, Lower J. Hepatitis C transmission associated with intravenous immunoglobulins. Lancet 1995; 345:1174.
13. Saldhana J, Minor P. Collaborative study to assess the suitability of a proposed working reagent for human parvovirus B19 DNA detection in plasma pools by gene amplification techniques. Vox Sang 1997; 73:207-11.
14. Rogers PM, Saldhana J, Allain JP, Report of EPFA/NIBSC workshop 'Nucleic acid amplification tests (NAT) for the detection of blood-borne viruses' held on 31 October 1996 in Amsterdam, the Netherlands. Vox Sang 1997; 72:199-206.
15. Mortimer J. Intersecting pools and their potential application in testing donated blood for viral genomes. Vox Sang 1997; 73:93-6.
16. Conry-Cantilena P, VanRaden M, Gibble J, et al. Routes of infection, viremia, and liver disease in blood donors found to have hepatitis C virus infection. N Engl J Med 1996; 334:1691-6.
17. Schottstedt V. Identification of a single viraemic donation with PCR-minipool testing in a large blood bank. Transfusion Med 1997; 7 (suppl):14.
18. Roth WK, Weber M, Tschauder S, Buhr S, Siefried E. Rapid routine PCR system for blood banks. Infusiontherapie und Transfusionsmedizin 1997; 24:218.
19. McOmish F, Yap PL, Jordan A, Hart H, Cohen BJ, Simmonds P. Detection of parvovirus B19 in donated blood: a model system for screening by polymerase chain reaction. J Clin Microbiol 1993: 31:323-8.
20. Petrik J, Pearson GJM, Allain JP. High throughput PCR detection of HCV based on semiautomated multisample RNA capture. J Virol Methods 1997; 64:147-59.
21. McDonough SH, Giachetti C, Yang Y, et al. A high throughput assay for the simultaneous or separate detection of human immunodeficiency virus (HIV) and hepatitis type C virus (HCV). Infusionstherapie und Transfusionsmedizin 1998; 25: in press.
22. Lelie PN, Cuypers HTM, Rogers P, et al. Standardisation of viral nucleic acid amplification methodology in blood safety testing. A risk benefit analysis. Infusiontherapie und Transfusionmedizin 1997; 24:220.